Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing post-treatment platelet reactivity: a focus on patient selection and setting.
Laine M, Frere C, Ronsin O, Gaubert M, Toesca R, Bessereau J, Michelet P, Gramond C, Helal O, Paganelli F, Bonello L. Laine M, et al. Among authors: helal o. Expert Rev Cardiovasc Ther. 2013 Nov;11(11):1557-66. doi: 10.1586/14779072.2013.820440. Epub 2013 Sep 2. Expert Rev Cardiovasc Ther. 2013. PMID: 23992465 Review.
Ticagrelor increases adenosine plasma concentration in patients with an acute coronary syndrome.
Bonello L, Laine M, Kipson N, Mancini J, Helal O, Fromonot J, Gariboldi V, Condo J, Thuny F, Frere C, Camoin-Jau L, Paganelli F, Dignat-George F, Guieu R. Bonello L, et al. Among authors: helal o. J Am Coll Cardiol. 2014 Mar 11;63(9):872-7. doi: 10.1016/j.jacc.2013.09.067. Epub 2013 Nov 27. J Am Coll Cardiol. 2014. PMID: 24291273 Free article. Clinical Trial.
Increased levels of microparticles originating from endothelial cells, platelets and erythrocytes in subjects with metabolic syndrome: relationship with oxidative stress.
Helal O, Defoort C, Robert S, Marin C, Lesavre N, Lopez-Miranda J, Risérus U, Basu S, Lovegrove J, McMonagle J, Roche HM, Dignat-George F, Lairon D. Helal O, et al. Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):665-71. doi: 10.1016/j.numecd.2010.01.004. Epub 2010 Apr 15. Nutr Metab Cardiovasc Dis. 2011. PMID: 20399083
Effects of dietary fat modification on oxidative stress and inflammatory markers in the LIPGENE study.
Petersson H, Risérus U, McMonagle J, Gulseth HL, Tierney AC, Morange S, Helal O, Shaw DI, Ruano JA, López-Miranda J, Kieć-Wilk B, Gołąbek I, Blaak EE, Saris WH, Drevon CA, Lovegrove JA, Roche HM, Basu S. Petersson H, et al. Among authors: helal o. Br J Nutr. 2010 Nov;104(9):1357-62. doi: 10.1017/S000711451000228X. Epub 2010 Jun 23. Br J Nutr. 2010. PMID: 20569506 Clinical Trial.
Dietary fat modifications and blood pressure in subjects with the metabolic syndrome in the LIPGENE dietary intervention study.
Gulseth HL, Gjelstad IM, Tierney AC, Shaw DI, Helal O, Hees AM, Delgado-Lista J, Leszczynska-Golabek I, Karlström B, Lovegrove J, Defoort C, Blaak EE, Lopez-Miranda J, Dembinska-Kiec A, Risérus U, Roche HM, Birkeland KI, Drevon CA. Gulseth HL, et al. Among authors: helal o. Br J Nutr. 2010 Jul;104(2):160-3. doi: 10.1017/S0007114510000565. Epub 2010 Mar 5. Br J Nutr. 2010. PMID: 20202290 Clinical Trial.
A Period 2 genetic variant interacts with plasma SFA to modify plasma lipid concentrations in adults with metabolic syndrome.
Garcia-Rios A, Perez-Martinez P, Delgado-Lista J, Phillips CM, Gjelstad IM, Wright JW, Karlström B, Kiec-Wilk B, van Hees AM, Helal O, Polus A, Defoort C, Riserus U, Blaak EE, Lovegrove JA, Drevon CA, Roche HM, Lopez-Miranda J. Garcia-Rios A, et al. Among authors: helal o. J Nutr. 2012 Jul;142(7):1213-8. doi: 10.3945/jn.111.156968. Epub 2012 May 23. J Nutr. 2012. PMID: 22623394 Free article.
Effects of dietary fat modification on insulin sensitivity and on other risk factors of the metabolic syndrome--LIPGENE: a European randomized dietary intervention study.
Tierney AC, McMonagle J, Shaw DI, Gulseth HL, Helal O, Saris WH, Paniagua JA, Gołąbek-Leszczyñska I, Defoort C, Williams CM, Karsltröm B, Vessby B, Dembinska-Kiec A, López-Miranda J, Blaak EE, Drevon CA, Gibney MJ, Lovegrove JA, Roche HM. Tierney AC, et al. Among authors: helal o. Int J Obes (Lond). 2011 Jun;35(6):800-9. doi: 10.1038/ijo.2010.209. Epub 2010 Oct 12. Int J Obes (Lond). 2011. PMID: 20938439 Clinical Trial.
Pleiotropic effects of TCF7L2 gene variants and its modulation in the metabolic syndrome: from the LIPGENE study.
Delgado-Lista J, Perez-Martinez P, García-Rios A, Phillips CM, Williams CM, Gulseth HL, Helal O, Blaak EE, Kiec-Wilk B, Basu S, Drevon CA, Defoort C, Saris WH, Wybranska I, Riserus U, Lovegrove JA, Roche HM, Lopez-Miranda J. Delgado-Lista J, et al. Among authors: helal o. Atherosclerosis. 2011 Jan;214(1):110-6. doi: 10.1016/j.atherosclerosis.2010.10.027. Epub 2010 Nov 3. Atherosclerosis. 2011. PMID: 21115178
Gene-nutrient interactions in the metabolic syndrome: single nucleotide polymorphisms in ADIPOQ and ADIPOR1 interact with plasma saturated fatty acids to modulate insulin resistance.
Ferguson JF, Phillips CM, Tierney AC, Pérez-Martínez P, Defoort C, Helal O, Lairon D, Planells R, Shaw DI, Lovegrove JA, Gjelstad IM, Drevon CA, Blaak EE, Saris WH, Leszczynska-Golabek I, Kiec-Wilk B, Risérus U, Karlström B, Miranda JL, Roche HM. Ferguson JF, et al. Among authors: helal o. Am J Clin Nutr. 2010 Mar;91(3):794-801. doi: 10.3945/ajcn.2009.28255. Epub 2009 Dec 23. Am J Clin Nutr. 2010. PMID: 20032495 Free article. Clinical Trial.
47 results